Nektar Therapeutics (NASDAQ:NKTR)

32.17
Delayed Data
As of 4:00pm ET
 -1.31 / -3.91%
Today’s Change
29.22
Today|||52-Week Range
108.23
-2.13%
Year-to-Date
3 Stocks That Could Double Your Money
Mar 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close33.48
Today’s open33.62
Day’s range32.14 - 34.00
Volume1,284,104
Average volume (3 months)2,095,480
Market cap$6.2B
Data as of 4:00pm ET, 03/22/2019

Growth & Valuation

Earnings growth (last year)+1,855.61%
Earnings growth (this year)-169.78%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+287.81%
P/E ratio8.5
Price/Sales4.96
Price/Book3.59

Competitors

 Today’s
change
Today’s
% change
TLRYTilray Inc-3.09-4.40%
MRNAModerna Inc-0.34-1.76%
NBIXNeurocrine Bioscienc...-4.71-5.24%
TECHBio-Techne Corp-8.10-4.04%
Data as of 4:00pm ET, 03/22/2019

Financials

Next reporting dateMay 6, 2019
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$1.2B
Annual profit (last year)$681.3M
Net profit margin57.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts